Holen Sie sich die Stockscreener-App
10.79
0.60%
-0.06
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$10.85
Offen:
$10.76
24-Stunden-Volumen:
96,413
Relative Volume:
0.17
Marktkapitalisierung:
$486.41M
Einnahmen:
$159.01M
Nettoeinkommen (Verlust:
$-21.72M
KGV:
-20.75
EPS:
-0.52
Netto-Cashflow:
$-20.63M
1W Leistung:
+6.26%
1M Leistung:
-0.96%
6M Leistung:
-34.56%
1J Leistung:
+39.88%
1-Tages-Spanne:
$10.58
$10.92
1-Wochen-Bereich:
$9.97
$11.11
52-Wochen-Spanne:
$7.17
$21.00
Axogen Inc Stock (AXGN) Company Profile
Firmenname
Axogen Inc
Sektor
Branche
Telefon
(386) 462-6817
Adresse
13631 PROGRESS BLVD., ALACHUA, FL
Vergleichen Sie AXGN mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
AXGN
Axogen Inc
|
10.79 | 486.41M | 159.01M | -21.72M | -20.63M | -0.52 |
|
ABT
Abbott Laboratories
|
136.99 | 233.36B | 42.34B | 13.50B | 6.66B | 7.71 |
|
BSX
Boston Scientific Corp
|
106.04 | 147.06B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
399.48 | 145.64B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
88.39 | 112.76B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
77.91 | 44.46B | 5.54B | 4.18B | 623.10M | 7.00 |
Axogen Inc Stock (AXGN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-03-17 | Eingeleitet | Lake Street | Buy |
| 2024-07-01 | Eingeleitet | Raymond James | Outperform |
| 2022-11-11 | Fortgesetzt | Jefferies | Buy |
| 2022-05-09 | Hochstufung | Canaccord Genuity | Hold → Buy |
| 2022-03-11 | Fortgesetzt | Cantor Fitzgerald | Overweight |
| 2020-10-23 | Eingeleitet | Guggenheim | Buy |
| 2020-06-16 | Fortgesetzt | Cantor Fitzgerald | Overweight |
| 2020-05-07 | Herabstufung | Canaccord Genuity | Buy → Hold |
| 2020-04-02 | Herabstufung | BTIG Research | Buy → Neutral |
| 2019-08-07 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2019-07-12 | Eingeleitet | Canaccord Genuity | Buy |
| 2018-03-02 | Bestätigt | Lake Street | Buy |
| 2018-01-05 | Fortgesetzt | Cantor Fitzgerald | Overweight |
| 2017-11-30 | Eingeleitet | Jefferies | Buy |
| 2017-11-21 | Bestätigt | Lake Street | Buy |
| 2017-07-31 | Eingeleitet | Leerink Partners | Outperform |
| 2017-06-30 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2017-03-06 | Eingeleitet | ROTH Capital | Buy |
| 2016-11-22 | Hochstufung | Lake Street | Hold → Buy |
| 2016-11-07 | Bestätigt | Wedbush | Outperform |
| 2016-11-03 | Herabstufung | Lake Street | Buy → Hold |
| 2016-08-04 | Bestätigt | Wedbush | Outperform |
| 2014-05-14 | Eingeleitet | Dawson James | Buy |
| 2013-10-31 | Bestätigt | Ladenburg Thalmann | Buy |
Alle ansehen
Axogen Inc Aktie (AXGN) Neueste Nachrichten
Institutional investors in Axogen, Inc. (NASDAQ:AXGN) see US$53m decrease in market cap last week, although long-term gains have benefitted them. - simplywall.st
Axogen Announces Appointment of Jesse Bishop as Vice President of Regulatory Affairs and Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - The Globe and Mail
AxoGen at Goldman Sachs Conference: Strategic Path to Nerve Repair Growth - Investing.com Canada
Transcript : Axogen, Inc. Presents at Goldman Sachs 46th Annual Global Healthcare Conference 2025, Jun-11-2025 02 - MarketScreener
Axogen, Inc. Reports 2024 Fourth Quarter and Full-Year Financial Results - The Globe and Mail
AxoGen, Inc. (NASDAQ:AXGN) Sees Significant Increase in Short Interest - Defense World
AxoGen FY2025 EPS Estimate Decreased by Cantor Fitzgerald - Defense World
Axogen Inc (AXGN) Trading Down 3.17% on Jun 4 - GuruFocus
LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In AxoGen, Inc. To Contact The Firm - ACCESS Newswire
AxoGen, Inc. (NASDAQ:AXGN) Shares Sold by Nuveen Asset Management LLC - Defense World
AxoGen, Inc. (NASDAQ:AXGN) Receives $22.20 Average Price Target from Analysts - Defense World
Millennium Management LLC Lowers Position in AxoGen, Inc. (NASDAQ:AXGN) - Defense World
ProShare Advisors LLC Invests $197,000 in AxoGen, Inc. (NASDAQ:AXGN) - Defense World
BNP Paribas Financial Markets Has $102,000 Stake in AxoGen, Inc. (NASDAQ:AXGN) - Defense World
Jane Street Group LLC Sells 30,670 Shares of AxoGen, Inc. (NASDAQ:AXGN) - Defense World
AxoGen, Inc. (NASDAQ:AXGN) Shares Bought by MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. - Defense World
Axogen, Inc to Participate at Goldman Sachs Global Healthcare Conference - GlobeNewswire
Bank of America Corp DE Reduces Stake in AxoGen, Inc. (NASDAQ:AXGN) - Defense World
AxoGen’s SWOT analysis: nerve repair innovator’s stock poised for growth By Investing.com - Investing.com Nigeria
AxoGen’s SWOT analysis: nerve repair innovator’s stock poised for growth - Investing.com Australia
Ameriprise Financial Inc. Has $4.81 Million Stock Holdings in AxoGen, Inc. (NASDAQ:AXGN) - Defense World
Insider Sell: Joseph Tyndall Sells 2,525 Shares of Axogen Inc (A - GuruFocus
Nerve Regeneration Market Deep Research Report with Forecast - openPR.com
AxoGen (AXGN) Loses 25.0% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner - Yahoo Finance
How To Trade (AXGN) - news.stocktradersdaily.com
Northern Trust Corp Boosts Stock Position in AxoGen, Inc. (NASDAQ:AXGN) - Defense World
The Manufacturers Life Insurance Company Sells 1,016 Shares of AxoGen, Inc. (NASDAQ:AXGN) - Defense World
Study Evaluating AxoGen Nerve Graft Complete - Medical Product Outsourcing
Canaccord Genuity Group Has Lowered Expectations for AxoGen (NASDAQ:AXGN) Stock Price - Defense World
Tower Research Capital LLC TRC Sells 1,087 Shares of AxoGen, Inc. (NASDAQ:AXGN) - Defense World
Nerve Wrap Market Size & Share | Industry Report, 2030 - Grand View Research
Cantor Fitzgerald Reduces Earnings Estimates for AxoGen - Defense World
Axogen (AXGN) Sees Price Target Reduction by Canaccord Genuity | - GuruFocus
Canaccord Adjusts AxoGen (AXGN) Price Target Following Q1 Updates | AXGN Stock News - GuruFocus
What Analysts Are Saying About Axogen Stock - Benzinga
Canaccord Adjusts AxoGen (AXGN) Price Target Following Q1 Update - GuruFocus
Price T Rowe Associates Inc. MD Has $574,000 Stock Position in AxoGen, Inc. (NASDAQ:AXGN) - Defense World
AxoGen stock target cut to $24 by Canaccord Genuity - Investing.com South Africa
AxoGen, Inc. (NASDAQ:AXGN) Q1 2025 Earnings Call Transcript - Insider Monkey
(AXGN) Long Term Investment Analysis - news.stocktradersdaily.com
Axogen, Inc. (NASDAQ:AXGN) Might Not Be As Mispriced As It Looks After Plunging 32% - simplywall.st
Axogen, Inc.'s (NASDAQ:AXGN) Intrinsic Value Is Potentially 87% Above Its Share Price - Yahoo Finance
Dimensional Fund Advisors LP Raises Stake in AxoGen, Inc. (NASDAQ:AXGN) - Defense World
AxoGen’s Earnings Call: Growth Amid Challenges - TipRanks
Breakeven On The Horizon For Axogen, Inc. (NASDAQ:AXGN) - simplywall.st
Balance Sheet Insights: Axogen Inc (AXGN)’s Debt-to-Equity and Long-Term Debt/Eq Ratios - DWinneX
Axogen, Inc. Reports 2025 First Quarter Financial Results - GlobeNewswire
Finanzdaten der Axogen Inc-Aktie (AXGN)
Umsatz
Nettogewinn
Free Cashflow
ENV
Axogen Inc-Aktie (AXGN) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Levine Alan M | Director |
Jun 09 '25 |
Sale |
10.61 |
4,073 |
43,215 |
36,743 |
| Wendell Amy McBride | Director |
Jun 09 '25 |
Sale |
10.61 |
4,073 |
43,215 |
93,826 |
| Burke William P. Mr. | Director |
Jun 09 '25 |
Sale |
10.61 |
4,073 |
43,215 |
24,484 |
| NEELS GUIDO J | Director |
Jun 09 '25 |
Sale |
10.61 |
4,073 |
43,215 |
86,743 |
| JOHNSON JOHN | Director |
Jun 09 '25 |
Sale |
10.61 |
4,073 |
43,215 |
24,943 |
| TYNDALL JOSEPH A. | Director |
Jun 10 '25 |
Option Exercise |
6.56 |
11,586 |
75,952 |
26,931 |
| TYNDALL JOSEPH A. | Director |
Jun 10 '25 |
Sale |
10.72 |
26,931 |
288,700 |
0 |
1.35%
0.46%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):